Suppr超能文献

庞贝病中的周围神经和神经肌肉接头病理学

Peripheral nerve and neuromuscular junction pathology in Pompe disease.

作者信息

Falk Darin J, Todd Adrian Gary, Lee Sooyeon, Soustek Meghan S, ElMallah Mai K, Fuller David D, Notterpek Lucia, Byrne Barry J

机构信息

Department of Pediatrics Powell Gene Therapy Center

Department of Pediatrics Powell Gene Therapy Center.

出版信息

Hum Mol Genet. 2015 Feb 1;24(3):625-36. doi: 10.1093/hmg/ddu476. Epub 2014 Sep 12.

Abstract

Pompe disease is a systemic metabolic disorder characterized by lack of acid-alpha glucosidase (GAA) resulting in ubiquitous lysosomal glycogen accumulation. Respiratory and ambulatory dysfunction are prominent features in patients with Pompe yet the mechanism defining the development of muscle weakness is currently unclear. Transgenic animal models of Pompe disease mirroring the patient phenotype have been invaluable in mechanistic and therapeutic study. Here, we demonstrate significant pathological alterations at neuromuscular junctions (NMJs) of the diaphragm and tibialis anterior muscle as prominent features of disease pathology in Gaa knockout mice. Postsynaptic defects including increased motor endplate area and fragmentation were readily observed in Gaa(-/-) but not wild-type mice. Presynaptic neuropathic changes were also evident, as demonstrated by significant reduction in the levels of neurofilament proteins, and alterations in axonal fiber diameter and myelin thickness within the sciatic and phrenic nerves. Our data suggest the loss of NMJ integrity is a primary contributor to the decline in respiratory and ambulatory function in Pompe and arises from both pre- and postsynaptic pathology. These observations highlight the importance of systemic phenotype correction, specifically restoration of GAA to skeletal muscle and the nervous system for treatment of Pompe disease.

摘要

庞贝病是一种全身性代谢紊乱疾病,其特征是缺乏酸性α-葡萄糖苷酶(GAA),导致溶酶体中糖原在全身蓄积。呼吸和行走功能障碍是庞贝病患者的突出特征,但目前尚不清楚导致肌肉无力的机制。反映患者表型的庞贝病转基因动物模型在机制和治疗研究中具有重要价值。在此,我们证明,在Gaa基因敲除小鼠中,膈肌和胫前肌神经肌肉接头(NMJ)处出现显著的病理改变,这是疾病病理的突出特征。在Gaa(-/-)小鼠而非野生型小鼠中,很容易观察到包括运动终板面积增加和碎片化在内的突触后缺陷。突触前神经病变也很明显,坐骨神经和膈神经中神经丝蛋白水平显著降低,轴突纤维直径和髓鞘厚度发生改变。我们的数据表明,NMJ完整性的丧失是庞贝病呼吸和行走功能下降的主要原因,且源于突触前和突触后病理改变。这些观察结果突出了全身性表型纠正的重要性,特别是将GAA恢复到骨骼肌和神经系统以治疗庞贝病。

相似文献

1
Peripheral nerve and neuromuscular junction pathology in Pompe disease.
Hum Mol Genet. 2015 Feb 1;24(3):625-36. doi: 10.1093/hmg/ddu476. Epub 2014 Sep 12.
2
Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease.
Ann Neurol. 2015 Aug;78(2):222-34. doi: 10.1002/ana.24433. Epub 2015 Jun 30.
3
Lentiviral gene therapy with IGF2-tagged GAA normalizes the skeletal muscle proteome in murine Pompe disease.
J Proteomics. 2024 Jan 16;291:105037. doi: 10.1016/j.jprot.2023.105037. Epub 2023 Oct 30.
4
The Respiratory Phenotype of Pompe Disease Mouse Models.
Int J Mol Sci. 2020 Mar 24;21(6):2256. doi: 10.3390/ijms21062256.
5
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase.
Mol Ther. 2020 Sep 2;28(9):2056-2072. doi: 10.1016/j.ymthe.2020.05.025. Epub 2020 May 30.
6
Small molecule inhibition of glycogen synthase I reduces muscle glycogen content and improves biomarkers in a mouse model of Pompe disease.
Am J Physiol Endocrinol Metab. 2024 Oct 1;327(4):E524-E532. doi: 10.1152/ajpendo.00175.2024. Epub 2024 Aug 22.
7
Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease.
Hum Gene Ther. 2019 Jan;30(1):57-68. doi: 10.1089/hum.2018.016. Epub 2018 Jul 25.
9
Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease.
Mol Ther. 2013 Sep;21(9):1661-7. doi: 10.1038/mt.2013.96. Epub 2013 Jun 4.
10
Neural deficits contribute to respiratory insufficiency in Pompe disease.
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9419-24. doi: 10.1073/pnas.0902534106. Epub 2009 May 27.

引用本文的文献

2
Novel transferrin receptor-mediated enzyme replacement therapy efficiently treats myogenic and neurogenic aspects of Pompe disease in mice.
Mol Ther Methods Clin Dev. 2025 Aug 7;33(3):101547. doi: 10.1016/j.omtm.2025.101547. eCollection 2025 Sep 11.
3
Gene therapy ameliorates neuromuscular pathology in CLN3 disease.
Acta Neuropathol Commun. 2025 Jul 23;13(1):160. doi: 10.1186/s40478-025-02059-z.
4
GAA replacement improves respiratory muscle, neural, and alveolar pathology in the pompe mouse.
Respir Physiol Neurobiol. 2025 Jul;335:104433. doi: 10.1016/j.resp.2025.104433. Epub 2025 Apr 25.
5
Respiratory pathology in the mdx/utrn -/- mouse: A murine model for Duchenne Muscular Dystrophy (DMD).
PLoS One. 2025 Feb 7;20(2):e0316295. doi: 10.1371/journal.pone.0316295. eCollection 2025.
7
Brain glycogen build-up measured by magnetic resonance spectroscopy in classic infantile Pompe disease.
Brain Commun. 2024 Sep 12;6(5):fcae303. doi: 10.1093/braincomms/fcae303. eCollection 2024.
8
Neuromuscular junction dysfunction in Lafora disease.
Dis Model Mech. 2024 Oct 1;17(10). doi: 10.1242/dmm.050905. Epub 2024 Oct 14.
9
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.
Mol Ther. 2024 Nov 6;32(11):3847-3864. doi: 10.1016/j.ymthe.2024.09.024. Epub 2024 Sep 17.

本文引用的文献

1
Glycogenosome accumulation in the arrector pili muscle in Pompe disease.
Orphanet J Rare Dis. 2014 Feb 5;9:17. doi: 10.1186/1750-1172-9-17.
5
Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice.
Mol Ther. 2014 Apr;22(4):702-12. doi: 10.1038/mt.2013.282. Epub 2013 Dec 12.
6
SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy.
Hum Mol Genet. 2014 May 1;23(9):2235-50. doi: 10.1093/hmg/ddt612. Epub 2013 Dec 2.
7
Terminal Schwann cells participate in the competition underlying neuromuscular synapse elimination.
J Neurosci. 2013 Nov 6;33(45):17724-36. doi: 10.1523/JNEUROSCI.3339-13.2013.
8
The respiratory neuromuscular system in Pompe disease.
Respir Physiol Neurobiol. 2013 Nov 1;189(2):241-9. doi: 10.1016/j.resp.2013.06.007. Epub 2013 Jun 21.
9
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy.
Orphanet J Rare Dis. 2013 Jun 20;8:90. doi: 10.1186/1750-1172-8-90.
10
Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease.
Mol Ther. 2013 Sep;21(9):1661-7. doi: 10.1038/mt.2013.96. Epub 2013 Jun 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验